drugset / Trial / NCT01537887

A Study of LY2484595 on the Electrical Activity of the Heart

NCT01537887

Phase 1 Completed 72 enrolled Eli Lilly and Company
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to evaluate the effect on the electrical activity of the heart as measured by an electrocardiogram (ECG) after dosing with 10 days of LY2484595 compared to 10 days of placebo in relation to a single dose of moxifloxacin. Information about any side effects that occur will also be collected.

Timeline

Start
2012-02
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Evacetrapib Small molecule 1200 mg Oral
Comparator Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.